• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高分辨率计算机断层扫描能准确预测肝门部胆管癌的可切除性。

High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.

作者信息

Aloia Thomas A, Charnsangavej Chusilp, Faria Silvana, Ribero Dario, Abdalla Eddie K, Vauthey J Nicholas, Curley Steven A

机构信息

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

出版信息

Am J Surg. 2007 Jun;193(6):702-6. doi: 10.1016/j.amjsurg.2006.10.024.

DOI:10.1016/j.amjsurg.2006.10.024
PMID:17512280
Abstract

INTRODUCTION

Despite the use of radiologic, endoscopic, and laparoscopic staging techniques, the rate of nontherapeutic laparotomies in patients with hilar cholangiocarcinoma remains high. This study evaluated the accuracy of preoperative high-resolution computed tomography (HRCT) to determine resectability in this setting.

PATIENTS AND METHODS

Preoperative helical HRCT (2 contrast phases, rapid intravenous contrast bolus, 2.5-mm section thickness) for 32 consecutive patients who underwent laparotomy for the diagnosis of hilar cholangiocarcinoma from 2000 to 2005 were reviewed by a hepatobiliary radiologist. The accuracy of HRCT was determined by comparison of the imaging interpretation to intraoperative and pathologic findings. The chi-square test was used to identify imaging findings that best predicted unresectability.

RESULTS

Fourteen of the 32 (44%) study patients were unresectable (extension along bile duct, 4; peritoneal metastases, 4; vascular encasement, 3; noncontiguous liver metastases, 2; N2 lymphadenopathy, 1). HRCT correctly predicted resectability in 17 of 18 patients who underwent therapeutic laparotomy (sensitivity = 94%). HRCT correctly predicted the inability to resect in 11 of the remaining 14 cases (specificity = 79%). In the 3 cases in which HRCT predicted resectability and the patient was unresectable, subcentimeter peritoneal disease, a subcentimeter liver metastasis, and distal bile duct involvement were responsible factors. The negative and positive predictive values of HRCT were 92% and 85%, respectively. Individual radiographic findings that best predicted unresectability were peritoneal spread (P = .015) and hepatic artery (P = .006) or portal vein (P = .002) involvement.

CONCLUSIONS

Preoperative HRCT accurately predicts resectability in patients with hilar cholangiocarcinoma. Identification of specific radiographic features, in particular major vascular involvement and peritoneal abnormalities, is now used by our group to avoid unnecessary laparotomy.

摘要

引言

尽管使用了放射学、内镜和腹腔镜分期技术,但肝门部胆管癌患者的非治疗性剖腹手术率仍然很高。本研究评估了术前高分辨率计算机断层扫描(HRCT)在这种情况下确定可切除性的准确性。

患者与方法

一位肝胆放射科医生回顾了2000年至2005年连续32例因诊断肝门部胆管癌而接受剖腹手术患者的术前螺旋HRCT(2个对比期,快速静脉注射造影剂团注,层厚2.5毫米)。通过将影像学解释与术中及病理结果进行比较来确定HRCT的准确性。采用卡方检验来识别最能预测不可切除性的影像学表现。

结果

32例研究患者中有14例(44%)不可切除(胆管侵犯,4例;腹膜转移,4例;血管包绕,3例;不连续肝转移,2例;N2淋巴结病,1例)。HRCT正确预测了18例接受治疗性剖腹手术患者中的17例的可切除性(敏感性=94%)。HRCT正确预测了其余14例中的11例无法切除(特异性=79%)。在HRCT预测可切除但患者不可切除的3例中,小于1厘米的腹膜病变、小于1厘米的肝转移和远端胆管受累是相关因素。HRCT的阴性和阳性预测值分别为92%和85%。最能预测不可切除性的个体影像学表现是腹膜播散(P=0.015)以及肝动脉(P=0.006)或门静脉(P=0.002)受累。

结论

术前HRCT能准确预测肝门部胆管癌患者的可切除性。我们团队现在利用识别特定的影像学特征,特别是主要血管受累和腹膜异常,来避免不必要的剖腹手术。

相似文献

1
High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.高分辨率计算机断层扫描能准确预测肝门部胆管癌的可切除性。
Am J Surg. 2007 Jun;193(6):702-6. doi: 10.1016/j.amjsurg.2006.10.024.
2
MDCT assessment of resectability in hilar cholangiocarcinoma.MDCT 评估肝门部胆管癌的可切除性。
Abdom Radiol (NY). 2017 Mar;42(3):851-860. doi: 10.1007/s00261-016-0943-0.
3
Preoperative assessment and staging of hilar cholangiocarcinoma with 16-multidetector computed tomography cholangiography and angiography.利用16排螺旋CT胆管造影和血管造影术对肝门部胆管癌进行术前评估和分期
Hepatogastroenterology. 2009 May-Jun;56(91-92):578-83.
4
Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma.多期螺旋CT在肝门部胆管癌诊断及分期中的应用
AJR Am J Roentgenol. 1998 Sep;171(3):651-8. doi: 10.2214/ajr.171.3.9725291.
5
Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography.多层螺旋计算机断层扫描对肝门部胆管癌的术前评估
J Hepatobiliary Pancreat Surg. 2007;14(5):434-40. doi: 10.1007/s00534-006-1191-4. Epub 2007 Sep 28.
6
Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma.三维成像在肝门部胆管癌手术规划中的作用。
Surgery. 2007 Nov;142(5):666-75. doi: 10.1016/j.surg.2007.05.018.
7
Multidetector computed tomography in the preoperative workup of hilar cholangiocarcinoma.多层螺旋计算机断层扫描在肝门部胆管癌术前检查中的应用
Acta Radiol. 2009 Oct;50(8):845-53. doi: 10.1080/02841850903092366.
8
Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma.术前影像学评分系统在确定可切除性方面的作用对于潜在可切除的肝门部胆管癌。
Eur J Surg Oncol. 2019 Feb;45(2):192-197. doi: 10.1016/j.ejso.2018.08.018. Epub 2018 Sep 11.
9
Staging of hilar cholangiocarcinoma with ultrasound.超声对肝门部胆管癌的分期
J Clin Ultrasound. 1995 Mar-Apr;23(3):173-8. doi: 10.1002/jcu.1870230305.
10
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.18F-FDG PET-CT在疑似及可能可手术切除的胆管癌中的临床作用:一项与传统成像对比的前瞻性研究
Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2.

引用本文的文献

1
Preoperative Imaging Assessment and Staging of Perihilar Cholangiocarcinoma: Tips and Pitfalls.肝门部胆管癌的术前影像评估与分期:技巧与陷阱
J Korean Soc Radiol. 2025 Jan;86(1):45-67. doi: 10.3348/jksr.2024.0055. Epub 2025 Jan 23.
2
Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.胆管癌:包括肝移植在内的手术选择现状
Cancers (Basel). 2024 May 21;16(11):1946. doi: 10.3390/cancers16111946.
3
Practice guidelines for managing extrahepatic biliary tract cancers.肝外胆管癌管理实践指南。
Ann Hepatobiliary Pancreat Surg. 2024 May 31;28(2):161-202. doi: 10.14701/ahbps.23-170. Epub 2024 Apr 29.
4
National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma.国家肝门部胆管癌诊断和治疗指南。
World J Gastroenterol. 2024 Mar 7;30(9):1018-1042. doi: 10.3748/wjg.v30.i9.1018.
5
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?重新审视肝门部恶性伪装:我们是否取得了进展?
Ann Surg Oncol. 2024 May;31(5):3062-3068. doi: 10.1245/s10434-024-14939-0. Epub 2024 Jan 28.
6
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.英国胃肠病学会胆管癌诊断和管理指南。
Gut. 2023 Dec 7;73(1):16-46. doi: 10.1136/gutjnl-2023-330029.
7
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives.对比增强成像在肝内胆管癌管理中的应用:现状与未来展望
Cancers (Basel). 2023 Jun 28;15(13):3393. doi: 10.3390/cancers15133393.
8
Locoregional Approaches in Cholangiocarcinoma Treatment.胆管癌治疗中的局部区域治疗方法。
Cancers (Basel). 2022 Nov 28;14(23):5853. doi: 10.3390/cancers14235853.
9
Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.正电子发射断层扫描(PET)在胃肠道肿瘤诊断与管理中的应用
Dig Dis Sci. 2022 Oct;67(10):4633-4653. doi: 10.1007/s10620-022-07616-3. Epub 2022 Jul 30.
10
Preoperative Management of Perihilar Cholangiocarcinoma.肝门部胆管癌的术前管理
Cancers (Basel). 2022 Apr 24;14(9):2119. doi: 10.3390/cancers14092119.